United States Biotechnology & Medical Research

Metacrine, Inc. (MTCR)

Track

Track

Ticker: MTCR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Klassen Preston President & CEO Executive Director
Transaction date
Sale
Price
467.25
Quantity 18,579 -15.9%
Value US$1,041,828
York Michael Chief Business Officer Officer
Transaction date
Sale
Price
276.04
Quantity 51,334 -45.3%
Value US$396,022
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
128.13
Quantity 81,595 -14.7%
Value US$2,157,586
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.38
Quantity 50,122 +0.8%
Value US$19,001
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.40
Quantity 101,384 +1.7%
Value US$40,554
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.39
Quantity 39,816 +0.7%
Value US$15,528
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.42
Quantity 123,954 +2.2%
Value US$52,346
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.40
Quantity 45,022 +0.8%
Value US$18,000
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.39
Quantity 767,507 +15.6%
Value US$299,328
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.35
Quantity 588,533 +13.6%
Value US$208,223
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.35
Quantity 499,279 +13.1%
Value US$175,596
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
0.34
Quantity 174,354 +4.8%
Value US$59,280
Klassen Preston President & CEO Executive Director
Transaction date
Sale
Price
0.51
Quantity 1,173 -0.1%
Value US$593
Klassen Preston President & CEO Executive Director
Transaction date
Sale
Price
0.50
Quantity 43,575 -4.5%
Value US$21,879
2.1
Sonsini Peter W. Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 769,230 +33.6%
Value US$9,999,990
2.5
BASKETT FOREST Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 769,230 +33.6%
Value US$9,999,990
2.8
Makhzoumi Mohamad Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 769,230 +33.6%
Value US$9,999,990
3.9
Walker Paul Edward Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 769,230 +33.6%
Value US$9,999,990
2.1
MAKOWER JOSHUA Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 769,230 +33.6%
Value US$9,999,990
2.4
SANDELL SCOTT D Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 769,230 +33.6%
Value US$9,999,990
2.5
Nashat Amir Non-Executive Director Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 15,038 +inf%
Value US$195,494
3.6
Chang Carmen Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 769,230 +33.6%
Value US$9,999,990
3.2
Burow Kristina Non-Executive Director
Transaction date
Purchase
Price
13.00
Quantity 20,000 +14.4%
Value US$260,000
3.2
Burow Kristina Non-Executive Director
Transaction date
Purchase
Price
13.00
Quantity 210,000 +8.2%
Value US$2,730,000
1.5
Behbahani Ali Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 769,230 +33.6%
Value US$9,999,990
2.7
Florence Anthony A. Jr. Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 769,230 +33.6%
Value US$9,999,990
2.5
Nashat Amir Non-Executive Director Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 214,962 +inf%
Value US$2,794,506
Adelman Robert J Non-Executive Director Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 230,000 +inf%
Value US$2,990,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-27 2023-01-26 S Sale
Klassen Preston

President & CEO

Executive Director
18,579 -15.9%
467.25
US$1,041,828 		18,579 -15.9% 467.25 US$1,041,828
2023-01-27 2023-01-26 S Sale
York Michael

Chief Business Officer

Officer
51,334 -45.3%
276.04
US$396,022 		51,334 -45.3% 276.04 US$396,022
2022-12-21 2022-12-21 B Purchase
2.9
Leonard Braden Michael
Large shareholder
81,595 -14.7%
128.13
US$2,157,586 		81,595 -14.7% 128.13 US$2,157,586
2022-12-21 2022-12-20 B Purchase
2.9
Leonard Braden Michael
Large shareholder
50,122 +0.8%
0.38
US$19,001 		50,122 +0.8% 0.38 US$19,001
2022-12-21 2022-12-19 B Purchase
2.9
Leonard Braden Michael
Large shareholder
101,384 +1.7%
0.40
US$40,554 		101,384 +1.7% 0.40 US$40,554
2022-11-09 2022-11-09 B Purchase
2.9
Leonard Braden Michael
Large shareholder
39,816 +0.7%
0.39
US$15,528 		39,816 +0.7% 0.39 US$15,528
2022-11-09 2022-11-08 B Purchase
2.9
Leonard Braden Michael
Large shareholder
500 +0.0%
0.40
US$200 		500 +0.0% 0.40 US$200
2022-11-09 2022-11-07 B Purchase
2.9
Leonard Braden Michael
Large shareholder
123,954 +2.2%
0.42
US$52,346 		123,954 +2.2% 0.42 US$52,346
2022-10-31 2022-10-28 B Purchase
2.9
Leonard Braden Michael
Large shareholder
45,022 +0.8%
0.40
US$18,000 		45,022 +0.8% 0.40 US$18,000
2022-10-31 2022-10-27 B Purchase
2.9
Leonard Braden Michael
Large shareholder
767,507 +15.6%
0.39
US$299,328 		767,507 +15.6% 0.39 US$299,328
2022-10-26 2022-10-26 B Purchase
2.9
Leonard Braden Michael
Large shareholder
588,533 +13.6%
0.35
US$208,223 		588,533 +13.6% 0.35 US$208,223
2022-10-26 2022-10-25 B Purchase
2.9
Leonard Braden Michael
Large shareholder
499,279 +13.1%
0.35
US$175,596 		499,279 +13.1% 0.35 US$175,596
2022-10-26 2022-10-24 B Purchase
2.9
Leonard Braden Michael
Large shareholder
174,354 +4.8%
0.34
US$59,280 		174,354 +4.8% 0.34 US$59,280
2022-04-20 2022-04-19 S Sale
Klassen Preston

President & CEO

Executive Director
1,173 -0.1%
0.51
US$593 		1,173 -0.1% 0.51 US$593
2022-04-20 2022-04-19 S Sale
Klassen Preston

President & CEO

Executive Director
43,575 -4.5%
0.50
US$21,879 		43,575 -4.5% 0.50 US$21,879
2021-10-26 2021-10-25 S Sale
0.6
venBio Global Strategic Fund, L.P.
Large shareholder
540,667 -18.1%
1.49
US$805,972 		540,667 -18.1% 1.49 US$805,972
2021-10-26 2021-10-22 S Sale
0.6
venBio Global Strategic Fund, L.P.
Large shareholder
75,035 -2.5%
1.64
US$122,930 		75,035 -2.5% 1.64 US$122,930
2020-09-22 2020-09-18 B Purchase
2.1
Sonsini Peter W.
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.5
BASKETT FOREST
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.8
Makhzoumi Mohamad
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
3.9
Walker Paul Edward
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.1
MAKOWER JOSHUA
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
1.2
New Enterprise Associates 16, L.P.
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
1.8
Polaris Management Co. VII, L.L.C.
Large shareholder
15,038 +inf%
13.00
US$195,494 		15,038 +inf% 13.00 US$195,494
2020-09-22 2020-09-18 B Purchase
2.5
Nashat Amir
Non-Executive Director Large shareholder
15,038 +inf%
13.00
US$195,494 		15,038 +inf% 13.00 US$195,494
2020-09-22 2020-09-18 B Purchase
3.6
Chang Carmen
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
3.2
Burow Kristina
Non-Executive Director
20,000 +14.4%
13.00
US$260,000 		20,000 +14.4% 13.00 US$260,000
2020-09-22 2020-09-18 B Purchase
3.2
Burow Kristina
Non-Executive Director
210,000 +8.2%
13.00
US$2,730,000 		210,000 +8.2% 13.00 US$2,730,000
2020-09-22 2020-09-18 B Purchase
ARCH Venture Fund VIII, L.P.
Large shareholder
20,000 +14.4%
13.00
US$260,000 		20,000 +14.4% 13.00 US$260,000
2020-09-22 2020-09-18 B Purchase
ARCH Venture Fund VIII, L.P.
Large shareholder
210,000 +8.2%
13.00
US$2,730,000 		210,000 +8.2% 13.00 US$2,730,000
2020-09-22 2020-09-18 B Purchase
1.5
Behbahani Ali
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.7
Florence Anthony A. Jr.
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.5
Nashat Amir
Non-Executive Director Large shareholder
214,962 +inf%
13.00
US$2,794,506 		214,962 +inf% 13.00 US$2,794,506
2020-09-22 2020-09-18 B Purchase
Adelman Robert J
Non-Executive Director Large shareholder
230,000 +inf%
13.00
US$2,990,000 		230,000 +inf% 13.00 US$2,990,000
2020-09-22 2020-09-18 B Purchase
1.8
Polaris Management Co. VII, L.L.C.
Large shareholder
214,962 +inf%
13.00
US$2,794,506 		214,962 +inf% 13.00 US$2,794,506
2020-09-22 2020-09-18 B Purchase
0.6
venBio Global Strategic Fund, L.P.

See Remarks

Large shareholder
230,000 +inf%
13.00
US$2,990,000 		230,000 +inf% 13.00 US$2,990,000
2020-09-18 2020-09-18 B Purchase
Alexandria Venture Investments, LLC
Large shareholder
38,461 +3.0%
13.00
US$499,993 		38,461 +3.0% 13.00 US$499,993
Explore more

More insider trading research around Metacrine, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America